• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    14 Hematopoietic System

    2015-03-22 06:06:40
    關(guān)鍵詞:楊力

    14 Hematopoietic System

    2015231 Clinical observations of lenalidomide combination chemotherapy for relapsing or refractory multiple myeloma.LI Xin(李新),et al.Dept Hematol,Beijing Chaoyang Hosp,Capital Med Univ,Beijing 100043.Natl Med J China 2015;95(10):745-748.

    Objective To explore the clinical efficacies and toxicities of lenalidomide combination chemotherapy in the treatment of relapsing or refractory multiple myeloma (MM)patients.Methods A total of 14 MM patients were recruited to receive lenalidomide combination chemotherapy in Beijing Chaoyang hospital from June 2013 to October 2014.Lenalidomide 25 mg was taken orally daily or every alternate day for 21 days and resting for 7 days.The regiments were RD(lenalidomide and dexamethasone,n=6),RCD(lenalidomide,ifosfamide and dexamethasone,n=4),RDD(lenalidomide,liposomal doxorubicinand dexamethasone,n=1),PRD( lenalido-mide,velcade and dexamethasone,n=1)and R+ DECP(lenalidomide,cisplatin,etoposide,ifosfamide and dexamethasone,n=2).Results Among them,two patients died during the first cycle of lenalidomide.Ten patients finished 2 cycles of treatment and 2 patients attained near complete remission or complete remission (nCR/CR),6 partial remission(PR)and 2 stable disease(SD)with an overall response rate(ORR)of 8/10. Ten patients finished 3 cycles of treatment and 3 attained CR,5 PR and 2 SD.Nine patients finished 4 cycles of treatment and 3 attained CR,5 PR and 1 progressive disease(PD).Six patients finished 5 cycles of treatment and 1 attained CR,3 PR and 2 PD.Three patients finished 6 cycles of treatment and 1 attained CR,1 PR and 1 PD.And the most common adverse reactions were fatigue,loss of appetite and hypocytosis.Six patients died.Conclusion The lenalidomide combination chemotherapy is both efficacious and safe in the treatment of relapsing or refractory MM.

    (Authors)

    2015232 Study on the molecular mechanisms of a novel large deletion of FⅩⅢA mRNA in a new hereditary factorⅩⅢdeficiency.MA Qiuling(馬秋玲),et al.Dept Biochem&Molec Biol,Hainan Med Coll,Haikou 571101.Chin J Hematol 2015;36(2):131-134.

    Objective To investigate the mechanisms of Del-CD11-279 of factorⅩⅢsubunit A mRNA in the pathogenesis of hereditary factorⅩⅢdeficiency.Methods The recombinant plasmids containing pET-22b(+)/FⅩⅢA of normal subject and proband's mother and pET-22b (+)/FⅩⅢA-Del of the proband were constructed and transformed into E.coli BL21.Expressing protein was analyzed by the SDS-PAGE and purified by Ni-NTA resin.Purified proteins were detected by the Western-blot. The activity of purified protein was detected by the incorporation test with EZ-LinkTM5-(Biotinamide)Pentylamine.Results The recombinant plasmids containing pET-22b(+)/FⅩⅢA and pET-22b(+)FⅩⅢA-Del which constructed and identified successfully by enzyme digestion and PCR,were transformed into E.coli BL21 and efficiently expressed by IPTG induction.The molecular weights of expressing proteins were 83 200 and 51 900 by the SDS-PAGE.Expressing proteins were purified by Ni-NTA resin,and were proven to be human FⅩⅢA proteins by Western-blot.Purified protein activity of proband's mother and proband was 95.87%and 0 of the purified FⅩⅢA protein activity from the normal subjects,respectively.Conclusion DelCD11-279 of FⅩⅢA mRNA which encoding a 464 amino acids of inactive FⅩⅢA protein is one of the molecular mechanisms resulting in FⅩⅢdeficiency in the patient.

    (Authors)

    2015233 Potential relationship and clinical significance of miRNAs and Th17 related cytokines in patients with multiple myeloma.LI Yanjie(李艷杰),et al.Dept Hematol,Affil Hosp,Xuzhou Med Coll,Xuzhou 221002.Chin J Hematol 2015;36(2):125-130.

    Objective To explore the expression and significance of miRNAs and Th17 related cytokines in patients with multiple myeloma(MM).Methods A total of 27 MM patients and 8 healthy controls were enrolled in this study.The expression of miR-15a/16,miR-34a,miR-194-2-192 cluster and miR-181a/b in bone marrow were detected by real-time quantitative PCR(qRT-PCR).Enzyme-linked immunosorbent assay(ELISA)was used to determine the levels of Th17 related cytokines interleukin-17(IL-17),IL-21,IL-22,IL-23 and IL-27 in peripheral blood plasma.The role of miRNAs and Th17 related cytokines was analyzed in the development of MM. Results The expression of miR-15a/16,miR-34a,miR-194-2-192 cluster in MM patients were significantly lower than those of the healthy controls,while miR-181a/b were exactly the reverse(P<0.05).The levels of IL-17,IL-21 and IL-27 were up-regulated in MM patients compared to healthy controls while IL-22 was down-regulated(P<0.05).There was no significant difference of IL-23 between the two groups.The levels of miRNAs and Th17 related cytokines had associated with ISS but not with some clinical parameters(such as gender,age,disease classification).Higher expression of IL-17,IL-21,IL-23,IL-27, miR-181a/b and lower expression of miR-15a/16,miR-34a,miR-194 and IL-22 were observed in the end stage than the early stage of MM patients(P<0.05).There was a significant correlation between miRNAs and Th17 elated cytokines.Conclusion Up-regulated IL-17,IL-21 and IL-27 may potentially down-regulate the expression of several miRNAs in MM patients. Establishment of the relationship may be useful for understanding the pathogenesis of MM and for clinical diagnosis of the disease.

    (Authors)

    2015234 ALK gene fusion associated non-small cell lung cancer:automated immunostainer detection and clinicopathologic perspectives.SHEN Qin(沈勤),et al.Dept Pathol,Jinling Hosp,South Med Univ,Nanjing 210002.Chin J Pathol 2015;44(3):164-169.

    Objective To explore the automated immunostainer screening anaplastic lymphoma kinase(ALK)gene fusion non-small cell lung cancer(NSCLC)and clinicopathological characteristics of the molecular subtype lung cancers.Methods Five hundred and sixty-six cases of NSCLC were collected over a 16 month period.The test for ALK was performed by Ventana automated immunostainer with anti-ALK D5F3.The histological features,treatment and outcome of patients were assessed.Results Thirty-eight cases(6.75,38/566)of NSCLC showed ALK gene fusion.The frequency of ALK gene fusion was higher in male(7.1%,25/350)than that in female (6.0%,13/216)patients,but not achieving statistical significance(χ2=0.270,P=0.604).ALK+NSCLC was more significantly frequent in patients≤60 years(9.9%,28/282)than>60 years(3.5%,10/284)of age.Histologically,the ALK+NSCLCs were mostly adenocarcinoma(81.6%,31/38),among which eighteen cases were solid predominant subtype with mucin production;nine cases were acinar predominant subtype;one case was papillary predominant subtype and three cases were invasive mucinous adenocarcinoma.The ALK+non-adenocarcinoma included three cases of squamous cell carcinoma,three cases of adenosquamous carcinoma and one case of pleomorphic carcinoma.Among the ALK+ NSCLC patients,the number of non/light cigarette smokers(86.8%,33/38)was more than that of heavy smokers.Twenty-nine cases were stagesⅢ andⅣ;twentynine cases showed lymph node metastasis;twenty cases showed metastases mostly to brain and bone;and one case showed EGFR gene mutation coexisting with ALK gene fusion.Twelve of fifteen patients received crizotinib therapy and remained stable.Conclusion NSCLC with ALK gene rearrangement shows distinctive clinical and histological features.Ventana-IHC may be a feasible and valid technique for detection of ALK rearrangement in NSCLC.

    (Authors)

    2015235 Clinical analysis of newly diagnosed multiple myeloma patients with renal dysfunction.ZHU Wanqiu(朱婉秋),et al.Beijing Chaoyang Hosp,Capital Med Univ,Beijing 100020.Natl Med J China 2015;95(10):741-744.

    Objective To explore the clinical features and prognostic factors of newly diagnosed multiple myeloma patients with renal insufficiency(MM-RI).Methods The clinical features,survival rates and prognostic factors were retrospectively analyzed for 897 newly diagnosed multiple myeloma(MM)patients at three hospitals from January 1,2010 to June 30,2012.Results Among them,there were 177 cases(19.7%)of MM-RI patients.There were 125 males and 52 females with an average age of 59 years.And 28.2%(50/177)were over 65 years.The types were 17.2%(30/174)of immunoglobulin(Ig)D-λ and 27.6%(48/174)of light chain isotype.And the stages were 94.9%of DS stageⅢ(167/176)and ISS stageⅢ(166/175).Compared with MM patients with normal renal function(MM-RN),MMRI group had a higher proportion of patients with IgD-λ and light chain isotype,more patients of DS and ISS stageⅢ;elevated bone marrow plasma cells,white blood cells and uric acid;lower hemoglobin and platelet (all P<0.05).After a median follow-up period of 24 (2-114)months,the median progression-free survival (PFS)was 28.0 months for MM-RI patients and 29.0 months for MM-RN patients.And the difference was not statistically significant(P=0.457) .The estimated medi-an overall survival(OS)was 44.0 months for MM-RI patients and 59.2 months for MM-RN patients.And the difference was statistically significant(P=0.033).Logrank univariate analysis showed that age,LDH,β2-MG,first-line treatment with or without bortezomib and previous transplantation or not were independent prognostic factors of MM patients.Conclusion MM-RI and MM-RN patients have different clinical features.Age,LDH,β2-MG,first-line treatment with or without bortezomib and previous transplantation or not are independent prognostic factors for newly diagnosed MM patients.

    (Authors)

    2015236 Clinical and cytogenetic characteristics of myeloma patients with overall survival less than 24 months.ZHANG Junling(張俊玲),et al.Dept Hematol,PUMC&CAMS,Beijing 100730.Natl Med J China 2015;95(10):736-740.

    Objective To explore the clinical characteristics of multiple myeloma(MM)patients with overall survival (OS)less than 24 months so as to stratify high-risk population.Methods A total of 177 newly diagnosed MM inpatients were recruited from July 2008 to July 2012. Clinical parameters at diagnosis of international staging system(ISS),lactic dehydrogenase(LDH),serum calcium,extramedullary involvement and amyloidosis were collected and cytogenetic abnormalities were detected by fluorescence in situ hybridization(FISH).Response and death were recorded as endpoints.Otherwise the followup period was over 24 months.Results And 73 patients dying within 24 months were classified into high-risk group while another 104 survivors for over 24 months into control group.Age and gender at baseline were comparable.However,OS of high-risk group was only 8 months while it was not attained during a median follow up of 38 months in control group(P<0.001).The most common cause of death was progressive disease in both groups. The pre-treatment percentages of the following parameters were significantly higher in high-risk group,including ISS stageⅢ[76.71%(56/73)vs 50.00%(52/104),P=0.002],renal dysfunction[47.95%(35/73)vs 31. 73%(33/140),P=0.029],elevated LDH[20.55%(15/73)vs 7.69%(8/104),P=0.015]and plasma cell leukemia[PCL,5.48%(4/73)vs 0(0/104),P= 0.016].Conversely,extramedullary involvement,plasmacytoma,amyloidosis and hypercalcemia were similar. Despite comparable chemotherapeutic regimens,the rate of deep response,including complete response(CR)and very good partial response(VGPR),was significant lower in high-risk group than that in control group[12.33% (9/73)vs 53.85%(56/104),P<0.001].Overall response rates[ORR,i.e.CR+VGPR+partial response (PR)]were markedly different[38.36%(28/73)vs 86.54%(90/104),P<0.001].Univariate analysis of cytogenetic abnormalities indicated a higher proportion of 1q21 amplification in high-risk group[35.62%(26/73)vs 25.15%(22/104),P=0.033].Multivariate Logistic regression revealed that ISS,LDH and primary response worse than PR independently affected early death (P=0.046,0.005,<0.001).Conclusion MM patients with OS less than 24 months have distinct clinical characteristics.And aggressive regimens are needed to improve the outcomes of high-risk population.

    (Authors)

    2015237 Effect of chronic graft versus host disease on relapse and survival in patients with acute myeloid leukemia.ZHAO Xiaoli(趙小利),et al.Dept Hematol,Chin PLA General Hosp,Beijing 100853.Chin J Hematol 2015;36(2):116-120.

    Objective To explore the influence of relapse and survival by chronic graft versus host disease(cGVHD)in patients with acute myeloid leukemia(AML)after allogeneichematopoieticsstemcelltransplantation(allo-HSCT).Methods Fifty-five AML patients received allo-HSCT were retrospectively reviewed.Relapse rate and overall survival(OS)were analyzed according to cGVHD. Results cGVHD significantly decreased the relapse rate of AML patients after transplantation within 2 years when compared with those without cGVHD(8.7%vs 38.6%,P=0.019),however,cGVHD had no effect on the long-term relapse rate(22.8%vs 5.9%,P=0.217). cGVHD had no effect on OS within 2 years(78.3%vs 61.0%,P=0.155) but could decrease the rate of long-term survival(63.7%vs100%,P=0.01).cGVHD also could reduce the rate of relapse(8.3%vs 46.2%,P=0.044)and enhanced the rate of survival(83.3% vs 47.2%,P=0.045)in patients with high risk AML after allo-HSCT in 2 years,while it had no effect on the relapse rate and OS in patients with low and intermediated risk AML in early and late phase.Moreover,compared with the rate of relapse(38.6%)in patients without cGVHD,the rate of relapse were lower in patients with limited cGVHD and intensive cGVHD(27.3%and 31.3%,respectively)but the long-term survival was significantly lower(53.3%,P=0.001)in those patients with intensive cGVHD after all-HSCT.Conclusion The benefit effect of cGVHD mainly took place within 2 years after allo-HSCT in AML patients especially in those with high risk,while in late phase after allo-HSCT,cGVHD especially intensive cGVHD had an effect on reducing long-term survival.

    (Authors)

    2015238 Effect of ERK1/2 inhibitor AZD8330 on human Burkitt's lymphoma cell line Raji cells and its mechanism.FENG Ke(馮可),et al.Dept Hematol,AffilCancerHosp, ZhengzhouUniv, Zhengzhou 450008.Chin J Hematol 2015;36(2):148-152.

    Objective To investigate the effect of ERK1/2 inhibitor AZD8330 on human Burkitt's lymphoma cell line Raji cells and its mechanism.Methods Raji cells were treated with different concentrations of AZD8330.CCK-8 was used to detect the cell viability.The apoptosis rate of Raji cells was detected by flow cytometry using Annexin Ⅴ/PI-staining.Real-time PCR was used to assess the expression of Bcl-2,Bcl-x1,caspase-3andVEGF genes.The protein expression level of Bcl-2,Bcl-x1,caspase-3 and p-ERK1/2 was tested with Western blot. Results The cell survival rate decreased to(62.09± 0.86)%,(50.06±1.33)%and(39.13±2.34)5 respectively after cells were treated with AZD8330 at 1.00 μmol/L in vitro for 24 h,48 h and 72 h,and statistically significant differences were observed in groups with different time of treatment(P<0.05).Apoptosis of cells treated with AZD8330 at 0.10,1.00,10.00 μmol/L in vitro for 24 h,48 h and 72 h was analyzed,and the statistically significant differences were observed in groups of different time and concentration treatment(P<0.05). AZD8330 induced Raji cell apoptosis and upregulated expression of Bcl-2,Bcl-x1,VEFG and decreased the expression of caspase-3 in a dose and time dependent manner,and statistically significant differences were observed in groups of different time and concentration treatment(P<0.05).At the same time,the Bcl-2,Bcl-x1 and p-ERK1/2 proteins expression was suppressed obviously,but the expression of caspase-3 protein increased. Conclusion AZD8330 induces cell apoptosis by downregulating the activation of ERK1/2 signal transduction pathway in Burkitt's lymphoma cell line Raji cells in a dose and time dependent manner.

    (Authors)

    2015239 Effect of ursolic acid on proliferation of T lymphoma cell lines Hut-78 cells and its mechanism. YANG Li(楊力),et al.Dept Hematol,1st Affil Hosp,Soochow Univ,Suzhou 215006.Chin J Hematol 2015;36(2):153-157.

    Objective To investigate the effects of ursolic acid on T cell lymphoma cell lines-Hut-78 cells and its mechanism.Methods Inhibition of Hut-78 cells proliferation by ursolic acid at different concentration(10,20,40 and 80 μmol/L)for different incubation time(4,12,24,48 and 72 h)was examined by MTT method,and early apoptosis by flow cytometry.The protein expressions of p65,p50,p52 and p100,and caspase-8,caspase-3 and caspase-9 were detected by Western blot.VEGF and COX-2 mRNA expressions were measured by reverse transcription polymerase chain reaction(RT-PCR).Results It was showed that ursolic acid inhibited proliferation of Hut-78 cells(P<0.05).Apoptosis of Hut-78 cells was induced by 10,20,40 and 80 μmol/L ursolic acid treatment(P<0.01).Likewise,expressions of p65 and p50 proteins were down-regulated by ursolic acid treatment(10,20,40 and 80 μmol/L)(P<0.01),but there was no significant change in the expression of p52 and p100.Moreover,ursolic acid could up-regulate expression of caspase-8, caspase-3 and caspase-9 protein(P<0.01).RT-PCR examination showed that VEGF and COX-2 mRNA expression decreased by ursolic acid treatment.Conclusion Inhibition of Hut-78 cell proliferation may be related to ursolic acid induced apoptosis through h death receptors and mitochondrial pathways. NF-κB classical signal pathway may be one of its mechanisms,and VEGF and cox-2 may also be involved.

    (Authors)

    2015240 Retrospective efficacy analysis of decitabine bridging allogeneic hematopoietic stem cell transplantation on the treatment of myelodysplastic syndrome.ZHENG Huifei(鄭慧菲),et al.Instit Hematol,1st Affil Hosp,Soochow Univ,Suzhou 215006. Chin J Hematol 2015;36(2):121-124.

    Objective To evaluate the efficacy of decitabine (DAC)bridging therapy followed by allogeneic hematopoietic stem cell transplantation(allo-HSCT)in patients with myelodysplastic syndrome(MDS).Methods The clinical characteristics and curative effect of MDS patients who received allo-HSCT from 2010 July to 2013 December were retrospectively analyzed.Of them,25 MDS patients who received decitabine bridging allo-HSCT were randomly selected(referred to as the bridging group),while at the same time another 33 MDS patients who did not receive decitabine for allo-HSCT in MDS were also randomly selected as control group.The effect of decitabine bridging allo-HSCT on the patients'survival and occurrence of graft versus host disease(GVHD)was analyzed.ResultsWithdecitabinebridgetherapy,64.0%patients(16/25)achieved marrow complete remission before allo-HSCT,while the control group was only 15.1%(5/33,P<0.05).Decitabine bridging group of early transplant-related mortality was lower than that of the control group(4.0%vs 18.2%),but the difference was not statistically significant(P=0.106). Up to follow-up deadline,the mortality of decitabine bridging group was 12.0%,while that of the control group was 30.3%(P<0.05).The 2-year OS of decitabine bridging group was 83.0%,while that of the control group was 59.0%(P<0.05).Of the 14 patients in decitabine bridging group with aGVHD,7 was gradeⅠ aGVHD,3 gradeⅡand 4 gradeⅢ.Of the 16 patients in control group with aGVHD,7 was gradeⅠaGVHD,8 gradeⅡ and 1 gradeⅢ.Conclusion Decitabine bridging therapy followed by allo-HSCT in the treatment of MDS is safe and effective.

    (Authors)

    2015241 Analysis of blood cell autophagy distribution in hematologic diseases by transmission electron microscope.DONG Shuxu(董樹(shù)旭),et al.Instit Hematol&Blood Dis Hosp,CAMS&PUMC,Tianjin 300020.Chin J Hematol 2015;36(2):144-147.

    Objective To investigate the distribution characteristics of blood cells autophagy in hematologic diseases,as well as their possible pathomechanism.Methods Retrospective analysis of electron microscopy specimens of 3 277 patients with hematological diseases were performed. The blood cells autophagy was observed by transmission electron microscopy,and its distribution characteristics were analyzed.The pathomechanism of blood cell autophagy was explored in combination with clinical examination and diagnosis.Results 15 samples were found to have mature granulocytes or nucleated erythrocytes autophagy.Of them,6 cases were myelodysplastic syndrome (MDS),2 acute leukemia,1 in each of aplastic anemia,pure red cell aplastic anemia,thalassemia,iron deficiency anemia,lymphoma,multiple myeloma and polycythemia vera.Among 15 cases,11 cases were found to have mature granulocytes autophagy,4 cases nucleated erythrocytes autophagy.Besides autophagy,apoptosis occurred in 9 cases,cytolysis in 6 cases,megaloblastic change in 5 cases.Conclusion Mature granulocytes or nucleated erythrocytes autophagy occurred more frequently in MDS among hematologic diseases,dyshaematopoiesisincludingapoptosis,cytolysisandmegaloblastic change could induce autophagy function enhancement.

    (Authors)

    2015242 Gene analysis in a family of hereditary hemorrhagic telangiectasia.YUAN Dong(袁冬),et al.Mudanjian 1st People's Hosp,Mudanjiang 157011. Chin J Hematol 2015;36(2):

    112-115.

    Objective To investigate the clinical feature of a familywithhereditaryhemorrhagictelangiectasia (HHT),and to study the mutation of its related genes. Methods Medical histories of the family were analyzed to detect HHT patients according to the diagnostic criteria. ENG and ALK-1 genes of the proband and her two daughters were analyzed.DNA from the three patients' peripheral blood was extracted.The exons 2-10 and their intron-exon boundaries of ALK1 were amplified with PCR,and then the PCR products were sequenced and analyzed to identify the mutation.Results 11 people in 41 family members of 4 generations were diagnosed as HHT.The proband and her two daughters suffered from multiple organ damage,the younger daughter appeared only imaging features instead of corresponding clinical symptoms.A missense mutation at the 1321 bp of cDNA (c.1321G>A)was detected in the exon 9 of ALK1,which resulted in valine 441 to methionine replacement in ALK-1 protein(p.Va1441Met).Conclusion A Chinese family with HHT was studied and a missense mutation(c.1321G>A,p.Va1441Met)of ALK-1 was discovered.This mutation is the genetic basis of the family with HHT and is reported for the first time in China. This research will not only help to further investigate molecular mechanism of pathogenesis of HTT,but also provide evidence and references for the following gene screening and genetic counseling on HTT family members.

    (Authors)

    2015243 A single-center clinical study of 22 patients with acquired hemophilia.YANG Chunchen(楊春晨),et al.1st Affil Hosp,Soochow Univ,Suzhou 215006.Chin J Hematol 2015;36(2):107-111.

    Objective To investigate the feature of underlying disorders,clinical symptoms,diagnosis and treatment strategies of patients with acquired hemophilia(AH). Methods The clinical data and laboratory test results of 22 patients with AH from March 2010 to June 2014 were retrospectively analyzed.Results A total of 22 patients with AH were enrolled in our study,including 20 patients diagnosed as acquired hemophilia A(AHA)and 2 as acquired hemophilia B(AHB).Among the AHA patients,there were 10 males and 10 females with the median age of 37.5(range,2-95)years old.The median activity of FⅧ(FⅧ:C)of the 20 AHA patients was 1.9% (0.5%-39.0%).Softtissuehematoma (80.0%)and subcutaneous bleeding(75.0%)were the most common clinical symptoms.Two male children were diagnosed as AHB(age 1 and 3 years old,respectively)with mild bleeding symptoms,and the activities of FⅨ(FⅨ:C)were 5.0%and 16.0%,respectively.In addition,an underlying disorder was found in 7 patients (31.8%).In laboratory testing,all patients had prolonged APTT,normal PT,decreased FⅧ:C or FⅨ:C,positive antibody screening test or antibody titer(2-32 BU),and negative for lupus anticoagulant and anticardiolipin antibody.Nineteen out of 20 patients were treated with blood products to stop acute bleeding episodes.Corticosteroid alone was applied to 7 patients,corticosteroid combined with other immunosuppressive agents to 11 patients,rituximab to 3 patients.Nineteen patients responded well to hemostatic treatment,except 1 patient who died of fatal bleeding.The FⅧ:C of 8 patients increased to a normal level with the median time of 42.5(21-145)days.After treatment,the activity of FⅨ:C of the 2 AHB patients achieved 35%and 24%in 48 and 60 days,respectively.Conclusion Acquired hemophilia is not an uncommon disease in clinical practice,which may occur in people of all ages.AH is a bleeding disorder with heterogeneous characteristics.Compared with adult,the clinical symptoms of children patients were mild,which leads to underdiagnosis.

    (Authors)

    2015244 A multicenter clinical trial of caffeic acid tablet in treatment of 103 primary immune thrombocytopenia patients.QIN Ping(秦平),et al.Dept Hematol,Qilu Hosp,Shandong Univ,Jinan 250012.Chin J Hematol 2015;36(2):103-106.

    Objective To determine the efficacy and safety of oral caffeic acid(CA)tablet in management of primary immune thrombocytopenia(ITP).Methods One hundred and three ITP patients with PLT>10×109/L and no serious bleeding symptoms from three centers were enrolled.According to their platelet count before CA treatment,these patients were divided into group A(PLT<30×109/L),including 24 females and 27 males with median age 48(18-84)years;and group B(PLT≥30×109/L),including 33 females and 19 males with median age 43(18-83)years.Patients in both groups took CA tablets orally of 300 mg three times per day for 12 consecutive weeks.Combined medicine treatment such as corticosteroids,danazol,TPO and Rituximab,which might increase the platelet count of these patients,were not allowed during CA therapy.Results In group A,the overall response rate was 51.0%(26/51),with 2 patients achieving complete response(CR)and 24 patients achieving response(R).Of 26 patients achieving response(CR+R),the median platelet count before CA therapy was 20.5(15-28)×109/L,and the median peak platelet count after CA therapy was 63(38-112)× 109/L.The median time to achieve response was 4 (2-10)weeks.Patients with pretreatment PLT>20× 109/L showed significantly better response than those PLT<20×109/L(68.0%vs 34.6%,P=0.017).In group B,the CR rate was 40.4%(21/52).Frequency of CA-related adverse events was 1.94%(2/103),including mild nausea in 1 case and elevation of liver enzymes in 1 case.Both were grade 1 and transient.Conclusion Caffeic acid was effective in patients with ITP with few and mild adverse effects.

    (Authors)

    2015245 Effectofimmunoglobulinheavy/light chain detection on the minimal residual disease monitoring in IgG multiple myeloma patients.ZHANG Hui(張慧),et al.Dept Hematol,Changzheng Hosp,2nd Milit Med Univ,Shanghai 200003.Chin J Hematol 2015;36(2):95-98.

    Objective To evaluate the specificity and sensitivity of immunoglobulin heavy/light chain(HLC)and serum free light chain(FLC)level in minimal residual disease monitoring of IgG type multiple myeloma(MM)patients during complete remission(CR).Methods Immunoglobulin HLC was assessed in 20 IgG myeloma patients by immune turbidimetry using SPAplus Analyzer.The serum level of HLC and FLC was detected at the same time. Combined with those obtained by serum protein electrophoresis(SPE)and immune fixation electrophoresis (IFE),the specificity and sensitivity of HLC in detection of serum immunoglobulin were analyzed.Combined with the clinical efficacy,kappa/lambda ratios of HLC (rHLC)and FLC(rFLC)were compared between the patients and normal controls.Results Among 20 patients,there were 10 male and 10 female,the median age was 56 years(35-70).There were 6 patients with abnormal rHLC but normal rFLC;3 patients with abnormal rFLC but normal HLC;and 11 patients with both normal rHLC and rFLC.During the mean follow-up time of 18 months,4 of the 6 patients with abnormal rHLC accepted intervention therapies,1 case relapsed in 9 months,the other 2 untreated patients relapsed in 3 months.Among the 3 cases with abnormal rFLC,2 patients are still in remission after intervention therapies,the other untreated patient relapsed in 1.5 months.A-mong the 11 untreated patients with both normal rHLC and rFLC,3 relapsed with the disease free survival time of 3.5 months,5.0 months and 5.5 months respectively.Conclusion The combined detection of HLC and FLC is helpful to assess the curative efficacy and the accuracy of minimal residual disease monitoring,and more effectively evaluate the prognosis of MM patients.Abnormal rHLC and rFLC are correlated with poor prognosis,while early intervention therapies can help to improve disease free survival.

    (Authors)

    2015246 The relationship between induction chemotherapy cycles and prognosis in patients with acute myeloid leukemia.ZHAO Ting(趙婷),et al.Peking Univ People's Hosp,Beijing 100044.Chin J Hematol 2015;36(2):89-94.

    Objective To explore the relationship between induction chemotherapy cycles to achieve complete remission(CR)and prognosis in patients with acute myeloid leukemia(AML).Methods From April 2004 to December 2013,397 adult patients with newly diagnosed AML (acute promyelocytic leukemia excluded)received the idarubicin combined with cytarabine(IA)“3+7”regimen as the first induction chemotherapy were enrolled in the study.Therapeutic effect,relapse and survival of these patients were discussed.Patients underwent continuous consolidation chemotherapy,and some eligible patients received allogeneic hematopoietic st em cell trans-plantation(allo-HSCT)in the first complete remission. Results Of 397 patients,347 valuable patients achieved CR after 1-4 cycles induction chemotherapy.The median follow-up was 18.0(2.4-115.4)months in survivors,the cumulative incidence of relapse(CIR),disease-free survival(DFS)and overall survival(OS)at 3 years were 33.0%,58.6%and 67.1%,respectively. Multivariate analysis revealed that unfavorable cytogenetics,more cycles to achieve CR and post-remission treatment without allo-HSCT were independent risk factors affecting DFS and OS.FLT3-ITD mutation positive was another independent risk factor affecting DFS.There was no statistic difference between patients who achieved CR after one cycle(n=255)and two cycles(n=73)treatment in DFS and OS(P>0.05).DFS and OS in patients who achieved CR after 3 or 4 cycles(n=19)were significantly lower than the above two groups(P<0.05).Multivariate analysis among 183 patients who received consistent chemotherapy showed that achieving CR within 2 cycles was the favorable factor affecting DFS and OS(P=0.001,P=0.035).Conclusion Achieving CR within 2 cycles of induction chemotherapy was associated with better prognosis among adult CR patients with AML.

    (Authors)

    猜你喜歡
    楊力
    一次“探險(xiǎn)”帶來(lái)的思考
    他的“左手”
    父女鐵索飛渡,綻放在懸崖上的“死亡舞蹈”
    星期一
    西部(2021年1期)2021-03-02 01:07:31
    心理扭曲的“激情”犯罪
    楊力:孤獨(dú)者住在大世界
    商周刊(2019年14期)2019-09-16 04:29:00
    楊力:徜徉在中華民族傳統(tǒng)文化的海洋里
    任性的好醫(yī)生
    做人與處世(2019年1期)2019-02-25 05:23:22
    楊力:我的文史哲醫(yī)夢(mèng)
    “40后”眼中的幸福經(jīng)濟(jì)學(xué)
    小康(2016年21期)2016-11-09 14:10:48
    九九在线视频观看精品| 丝瓜视频免费看黄片| 69av精品久久久久久| 亚洲美女视频黄频| 日本-黄色视频高清免费观看| 80岁老熟妇乱子伦牲交| 啦啦啦啦在线视频资源| 性插视频无遮挡在线免费观看| 在线观看三级黄色| 街头女战士在线观看网站| 伦理电影大哥的女人| 免费人成在线观看视频色| 黄色视频在线播放观看不卡| 日日摸夜夜添夜夜爱| 菩萨蛮人人尽说江南好唐韦庄| 日韩一本色道免费dvd| 99久久精品一区二区三区| 美女视频免费永久观看网站| 欧美成人一区二区免费高清观看| 嫩草影院精品99| 久久精品久久久久久噜噜老黄| 亚洲欧美精品自产自拍| 国产伦精品一区二区三区四那| 亚洲国产成人一精品久久久| 亚洲精品日本国产第一区| 丰满少妇做爰视频| av一本久久久久| 男女下面进入的视频免费午夜| av.在线天堂| 特级一级黄色大片| 亚洲丝袜综合中文字幕| 亚洲精品一区蜜桃| 国产美女午夜福利| 日日摸夜夜添夜夜爱| 国产欧美另类精品又又久久亚洲欧美| 又大又黄又爽视频免费| 少妇人妻久久综合中文| 五月伊人婷婷丁香| 麻豆国产97在线/欧美| 国产免费一区二区三区四区乱码| 视频中文字幕在线观看| av免费在线看不卡| 一级毛片电影观看| 狂野欧美激情性xxxx在线观看| 成人特级av手机在线观看| 偷拍熟女少妇极品色| 2021少妇久久久久久久久久久| 国产片特级美女逼逼视频| 下体分泌物呈黄色| 欧美成人a在线观看| 亚洲国产欧美在线一区| 久久99蜜桃精品久久| 高清午夜精品一区二区三区| 亚洲av二区三区四区| 在线观看一区二区三区| 中文字幕免费在线视频6| 精品一区二区三区视频在线| 亚州av有码| 亚洲欧洲国产日韩| 亚洲精品,欧美精品| 亚洲精品aⅴ在线观看| 老女人水多毛片| 天堂俺去俺来也www色官网| 春色校园在线视频观看| 久久韩国三级中文字幕| 国产精品久久久久久精品电影小说 | 中文字幕亚洲精品专区| 又爽又黄无遮挡网站| 国产亚洲一区二区精品| 99热这里只有是精品在线观看| 好男人视频免费观看在线| 国精品久久久久久国模美| 男女国产视频网站| 久久久精品94久久精品| xxx大片免费视频| 日韩不卡一区二区三区视频在线| 交换朋友夫妻互换小说| 欧美三级亚洲精品| 大陆偷拍与自拍| 日韩,欧美,国产一区二区三区| 亚洲精华国产精华液的使用体验| 亚洲av不卡在线观看| 亚洲精品第二区| 精品久久久精品久久久| 一个人观看的视频www高清免费观看| 少妇裸体淫交视频免费看高清| 青春草亚洲视频在线观看| 我要看日韩黄色一级片| 麻豆国产97在线/欧美| 国产成人精品婷婷| av一本久久久久| 丰满人妻一区二区三区视频av| 久久久成人免费电影| 97人妻精品一区二区三区麻豆| 久久99精品国语久久久| 亚洲一区二区三区欧美精品 | 亚洲精品国产色婷婷电影| 国产av不卡久久| 亚洲av福利一区| 亚洲av.av天堂| 亚洲av.av天堂| 草草在线视频免费看| 免费观看a级毛片全部| 亚洲真实伦在线观看| 在线观看av片永久免费下载| 亚洲电影在线观看av| av天堂中文字幕网| 亚洲av二区三区四区| 国产免费福利视频在线观看| 国产黄频视频在线观看| 97超视频在线观看视频| 黑人高潮一二区| 久久久久久伊人网av| 亚州av有码| eeuss影院久久| 精华霜和精华液先用哪个| 蜜臀久久99精品久久宅男| 亚洲精品日韩在线中文字幕| 3wmmmm亚洲av在线观看| 一边亲一边摸免费视频| 久久久精品94久久精品| 国产av不卡久久| 啦啦啦在线观看免费高清www| 搡老乐熟女国产| av国产精品久久久久影院| 国产在视频线精品| 热99国产精品久久久久久7| 好男人在线观看高清免费视频| 一本久久精品| 免费观看的影片在线观看| av国产久精品久网站免费入址| 免费观看的影片在线观看| 在线 av 中文字幕| 成人无遮挡网站| 亚洲综合精品二区| 国产黄色视频一区二区在线观看| 久久久久国产精品人妻一区二区| 欧美高清性xxxxhd video| 免费看av在线观看网站| 久久精品国产鲁丝片午夜精品| 在线观看人妻少妇| 男女无遮挡免费网站观看| 久久精品国产亚洲av涩爱| 国产黄片美女视频| 成年女人看的毛片在线观看| 国产精品一区二区性色av| av在线蜜桃| 国产女主播在线喷水免费视频网站| 91久久精品电影网| 91午夜精品亚洲一区二区三区| 亚洲精品亚洲一区二区| 亚洲精品视频女| 欧美亚洲 丝袜 人妻 在线| 亚洲欧美精品专区久久| 少妇人妻一区二区三区视频| 国产一区二区在线观看日韩| 99热国产这里只有精品6| 视频区图区小说| 国产精品爽爽va在线观看网站| 午夜免费鲁丝| 日韩免费高清中文字幕av| 狂野欧美白嫩少妇大欣赏| 性色av一级| 别揉我奶头 嗯啊视频| 国产精品麻豆人妻色哟哟久久| 80岁老熟妇乱子伦牲交| 亚洲色图av天堂| 亚洲第一区二区三区不卡| 久久久亚洲精品成人影院| 国产 一区精品| 菩萨蛮人人尽说江南好唐韦庄| 国产精品人妻久久久影院| 亚洲欧洲日产国产| 免费大片18禁| 天天躁日日操中文字幕| 精品久久久精品久久久| 性色av一级| 久久久久久久久久久丰满| 亚洲欧美成人精品一区二区| 亚洲成色77777| 国产亚洲5aaaaa淫片| 美女国产视频在线观看| 亚州av有码| 久久久久久国产a免费观看| 观看美女的网站| 99久国产av精品国产电影| 丝袜脚勾引网站| 女的被弄到高潮叫床怎么办| 真实男女啪啪啪动态图| 80岁老熟妇乱子伦牲交| 亚洲av二区三区四区| 在线观看av片永久免费下载| 国产精品成人在线| 草草在线视频免费看| 国产亚洲91精品色在线| 久久综合国产亚洲精品| 天天躁日日操中文字幕| 美女cb高潮喷水在线观看| 午夜爱爱视频在线播放| 特大巨黑吊av在线直播| av专区在线播放| 少妇的逼水好多| 国产伦在线观看视频一区| 国产有黄有色有爽视频| 亚洲av国产av综合av卡| 99热国产这里只有精品6| 高清av免费在线| 黄色怎么调成土黄色| 国产片特级美女逼逼视频| 欧美性感艳星| 少妇猛男粗大的猛烈进出视频 | 久久久精品免费免费高清| 三级男女做爰猛烈吃奶摸视频| 亚洲最大成人中文| av在线观看视频网站免费| 国产av不卡久久| 视频中文字幕在线观看| 最近手机中文字幕大全| 免费看日本二区| 久热久热在线精品观看| 又爽又黄无遮挡网站| 狠狠精品人妻久久久久久综合| 成人一区二区视频在线观看| 天天一区二区日本电影三级| 日本免费在线观看一区| 2022亚洲国产成人精品| 99久久精品热视频| 国产亚洲91精品色在线| 色视频在线一区二区三区| 免费观看的影片在线观看| 97精品久久久久久久久久精品| 国产v大片淫在线免费观看| 亚洲人成网站高清观看| 亚洲人成网站在线观看播放| .国产精品久久| 午夜福利在线在线| 黑人高潮一二区| 卡戴珊不雅视频在线播放| 国产成人aa在线观看| 又爽又黄a免费视频| 免费看光身美女| 国产女主播在线喷水免费视频网站| 欧美亚洲 丝袜 人妻 在线| 免费电影在线观看免费观看| 搡老乐熟女国产| 久久久色成人| 亚洲不卡免费看| 久久精品国产亚洲av涩爱| 国产免费福利视频在线观看| 中文欧美无线码| 3wmmmm亚洲av在线观看| 久久久久久国产a免费观看| 色视频在线一区二区三区| 五月天丁香电影| 尤物成人国产欧美一区二区三区| 亚洲无线观看免费| 国产永久视频网站| 一级毛片 在线播放| 国产成人a∨麻豆精品| 亚洲欧美日韩另类电影网站 | 国产av不卡久久| 婷婷色综合www| 亚洲精品国产av蜜桃| 白带黄色成豆腐渣| 男的添女的下面高潮视频| 亚洲伊人久久精品综合| 青春草亚洲视频在线观看| 插阴视频在线观看视频| 久久精品久久久久久久性| av在线老鸭窝| 成人高潮视频无遮挡免费网站| 国产女主播在线喷水免费视频网站| 日韩伦理黄色片| 欧美国产精品一级二级三级 | 亚洲无线观看免费| 制服丝袜香蕉在线| 又大又黄又爽视频免费| 在线观看国产h片| 五月天丁香电影| 国产精品麻豆人妻色哟哟久久| 黄色一级大片看看| 午夜日本视频在线| 各种免费的搞黄视频| 一本久久精品| 亚洲久久久久久中文字幕| 欧美人与善性xxx| 久久久久久九九精品二区国产| 亚洲自偷自拍三级| 久久国内精品自在自线图片| 日本一本二区三区精品| 在线a可以看的网站| 日韩制服骚丝袜av| 日本av手机在线免费观看| 欧美xxxx性猛交bbbb| 成人美女网站在线观看视频| 精品国产露脸久久av麻豆| 久久精品国产自在天天线| 久久久久久久精品精品| 久久精品国产亚洲网站| 国产欧美日韩精品一区二区| 大话2 男鬼变身卡| 黄片wwwwww| 欧美xxxx黑人xx丫x性爽| 亚洲国产成人一精品久久久| 岛国毛片在线播放| av国产免费在线观看| 精品少妇久久久久久888优播| 香蕉精品网在线| 国产男女超爽视频在线观看| 国产精品人妻久久久影院| 亚洲国产色片| 成人午夜精彩视频在线观看| 欧美亚洲 丝袜 人妻 在线| 欧美日韩国产mv在线观看视频 | 国产乱来视频区| a级一级毛片免费在线观看| 熟女电影av网| 黄片无遮挡物在线观看| 国产精品三级大全| 亚洲欧美日韩另类电影网站 | 乱系列少妇在线播放| 久久精品熟女亚洲av麻豆精品| 日韩人妻高清精品专区| 高清av免费在线| 国产精品一区www在线观看| 亚洲av中文字字幕乱码综合| 欧美精品人与动牲交sv欧美| 国产男女内射视频| 欧美xxxx性猛交bbbb| 久久久久久久久久成人| 久久久久久伊人网av| 午夜爱爱视频在线播放| 可以在线观看毛片的网站| 国产极品天堂在线| 97在线视频观看| 特大巨黑吊av在线直播| 久久鲁丝午夜福利片| 视频区图区小说| av国产精品久久久久影院| 欧美3d第一页| 久久鲁丝午夜福利片| 亚洲天堂av无毛| 美女xxoo啪啪120秒动态图| 免费在线观看成人毛片| 80岁老熟妇乱子伦牲交| 久久久亚洲精品成人影院| 亚洲欧洲日产国产| 在线免费十八禁| 国产色婷婷99| 亚洲电影在线观看av| 五月玫瑰六月丁香| 日本欧美国产在线视频| 国产综合懂色| 国产精品久久久久久久电影| 亚洲国产精品专区欧美| 最后的刺客免费高清国语| 伊人久久国产一区二区| av天堂中文字幕网| 菩萨蛮人人尽说江南好唐韦庄| 亚洲色图综合在线观看| 在线亚洲精品国产二区图片欧美 | 亚洲国产色片| 欧美 日韩 精品 国产| 国产精品不卡视频一区二区| 美女主播在线视频| 亚洲国产最新在线播放| 免费人成在线观看视频色| 亚洲精品视频女| 嫩草影院新地址| 直男gayav资源| 亚洲av日韩在线播放| 国国产精品蜜臀av免费| 国产中年淑女户外野战色| 人妻制服诱惑在线中文字幕| 中国三级夫妇交换| 亚洲av免费高清在线观看| 亚洲av成人精品一区久久| 1000部很黄的大片| 久久人人爽av亚洲精品天堂 | 成人鲁丝片一二三区免费| 久久精品国产亚洲av涩爱| 精品国产三级普通话版| 日韩免费高清中文字幕av| 国产免费又黄又爽又色| 欧美日韩在线观看h| 色播亚洲综合网| 丝袜喷水一区| 国产永久视频网站| 搡老乐熟女国产| 男人狂女人下面高潮的视频| 免费大片黄手机在线观看| 菩萨蛮人人尽说江南好唐韦庄| 丰满少妇做爰视频| 国产色婷婷99| 午夜日本视频在线| 69人妻影院| 女的被弄到高潮叫床怎么办| av天堂中文字幕网| 国产成人精品婷婷| 美女视频免费永久观看网站| 久久久久久久久久人人人人人人| 午夜激情久久久久久久| 91精品国产九色| 最近中文字幕2019免费版| 国产成人福利小说| 欧美成人精品欧美一级黄| 精品国产一区二区三区久久久樱花 | 乱系列少妇在线播放| 内射极品少妇av片p| 国产精品秋霞免费鲁丝片| 国产精品熟女久久久久浪| 欧美日本视频| 免费播放大片免费观看视频在线观看| 男人爽女人下面视频在线观看| 日日摸夜夜添夜夜添av毛片| 日韩欧美精品v在线| 亚洲aⅴ乱码一区二区在线播放| 国产 一区 欧美 日韩| 成人毛片a级毛片在线播放| 久久影院123| 女的被弄到高潮叫床怎么办| 最近中文字幕2019免费版| 国产一区亚洲一区在线观看| 亚洲欧美日韩另类电影网站 | 爱豆传媒免费全集在线观看| 午夜免费鲁丝| 成人鲁丝片一二三区免费| 国产精品.久久久| 精品午夜福利在线看| 久久精品国产亚洲网站| 伦理电影大哥的女人| 国产欧美另类精品又又久久亚洲欧美| 久久精品夜色国产| 特级一级黄色大片| 亚洲综合色惰| 亚洲人与动物交配视频| 欧美激情久久久久久爽电影| 国产精品国产三级国产av玫瑰| 欧美xxxx性猛交bbbb| 看免费成人av毛片| 免费不卡的大黄色大毛片视频在线观看| 水蜜桃什么品种好| 特级一级黄色大片| 高清日韩中文字幕在线| 狂野欧美激情性bbbbbb| 黄色配什么色好看| 国产成人福利小说| 内地一区二区视频在线| 只有这里有精品99| 高清欧美精品videossex| 国产成人freesex在线| 大片电影免费在线观看免费| 日本三级黄在线观看| 神马国产精品三级电影在线观看| 亚洲,一卡二卡三卡| 午夜视频国产福利| 一区二区av电影网| 99热6这里只有精品| 国产精品一区二区在线观看99| 精品一区在线观看国产| 尤物成人国产欧美一区二区三区| 男的添女的下面高潮视频| 啦啦啦中文免费视频观看日本| 麻豆成人av视频| 日韩欧美一区视频在线观看 | 亚洲国产最新在线播放| 麻豆成人av视频| 我要看日韩黄色一级片| 亚洲天堂国产精品一区在线| 只有这里有精品99| 日本一二三区视频观看| 亚洲无线观看免费| 国产高清国产精品国产三级 | 日韩一区二区视频免费看| 免费电影在线观看免费观看| 成年av动漫网址| av在线观看视频网站免费| 亚洲成人久久爱视频| 国产免费福利视频在线观看| 丰满少妇做爰视频| 黄色日韩在线| 国产精品久久久久久av不卡| 亚洲色图av天堂| 91在线精品国自产拍蜜月| 人人妻人人看人人澡| 日本猛色少妇xxxxx猛交久久| av在线老鸭窝| 日韩不卡一区二区三区视频在线| 国产 精品1| 最近中文字幕2019免费版| 久久99热这里只频精品6学生| 免费黄频网站在线观看国产| 精品人妻视频免费看| 大香蕉97超碰在线| 亚洲欧美日韩东京热| 国产欧美另类精品又又久久亚洲欧美| 中文在线观看免费www的网站| 国产精品一及| av在线app专区| 国产精品av视频在线免费观看| 欧美丝袜亚洲另类| 久久女婷五月综合色啪小说 | 中文乱码字字幕精品一区二区三区| 大香蕉久久网| 久久综合国产亚洲精品| 国产又色又爽无遮挡免| 国产成年人精品一区二区| 欧美高清性xxxxhd video| 亚洲成人精品中文字幕电影| 水蜜桃什么品种好| 永久网站在线| 国产免费一区二区三区四区乱码| 久久久久国产网址| 国产高清国产精品国产三级 | 黄色欧美视频在线观看| 久久久久久久久大av| 女的被弄到高潮叫床怎么办| 婷婷色麻豆天堂久久| 国产成人aa在线观看| 精品熟女少妇av免费看| 亚洲国产最新在线播放| 老司机影院毛片| 91在线精品国自产拍蜜月| 国产精品一区二区三区四区免费观看| 我要看日韩黄色一级片| 午夜视频国产福利| 高清日韩中文字幕在线| 欧美成人午夜免费资源| 亚洲熟女精品中文字幕| 青春草国产在线视频| 国产永久视频网站| 老司机影院成人| 高清午夜精品一区二区三区| 亚洲精品影视一区二区三区av| 久久精品国产亚洲av涩爱| 成人特级av手机在线观看| 午夜精品一区二区三区免费看| 久久久久久久久大av| 蜜桃久久精品国产亚洲av| 免费观看a级毛片全部| a级毛色黄片| 22中文网久久字幕| 美女cb高潮喷水在线观看| 精品酒店卫生间| 听说在线观看完整版免费高清| 欧美一级a爱片免费观看看| 99热国产这里只有精品6| 国产精品蜜桃在线观看| 97人妻精品一区二区三区麻豆| 久久精品国产亚洲网站| 在线观看av片永久免费下载| 国产精品嫩草影院av在线观看| 国产熟女欧美一区二区| 好男人视频免费观看在线| 大香蕉久久网| 日本爱情动作片www.在线观看| 国产伦在线观看视频一区| 青春草亚洲视频在线观看| 国产成人午夜福利电影在线观看| 国产成人福利小说| 日韩电影二区| 五月玫瑰六月丁香| 真实男女啪啪啪动态图| 亚洲国产精品专区欧美| 女的被弄到高潮叫床怎么办| 成人黄色视频免费在线看| 欧美极品一区二区三区四区| 美女主播在线视频| 韩国av在线不卡| 寂寞人妻少妇视频99o| 久久午夜福利片| 人人妻人人爽人人添夜夜欢视频 | av在线播放精品| 91狼人影院| 搡老乐熟女国产| 成人午夜精彩视频在线观看| 精品午夜福利在线看| 久久久a久久爽久久v久久| 色吧在线观看| av在线老鸭窝| 自拍欧美九色日韩亚洲蝌蚪91 | 中文精品一卡2卡3卡4更新| 午夜精品一区二区三区免费看| 成人国产av品久久久| 精品亚洲乱码少妇综合久久| 99热网站在线观看| 精品人妻一区二区三区麻豆| 美女国产视频在线观看| 尤物成人国产欧美一区二区三区| 久久久成人免费电影| 极品少妇高潮喷水抽搐| 99久久精品热视频| 久久精品国产鲁丝片午夜精品| 国产伦精品一区二区三区视频9| 欧美极品一区二区三区四区| 97人妻精品一区二区三区麻豆| 91精品国产九色| 亚洲精品成人久久久久久| 亚洲av不卡在线观看| 国产一区二区在线观看日韩| 中文字幕制服av| 亚洲欧美成人综合另类久久久| 久久精品国产亚洲av天美| 国产精品av视频在线免费观看| 内地一区二区视频在线| 精品久久久久久电影网| 丝袜喷水一区| 国产亚洲最大av| 久久久久久久久久成人| 亚洲aⅴ乱码一区二区在线播放| 国产av码专区亚洲av| 禁无遮挡网站| 国产高潮美女av| 99热6这里只有精品| 中文欧美无线码|